The mechanisms through which the oncoprotein c-Myc initiates locus-speci®c gene ampli®cation are not understood. When analysing the initiation mechanism of cMyc-dependent ampli®cation of the mouse ribonucleotide reductase R2 (R2) gene, we observe c-Myc-dependent initiation of illegitimate DNA replication of the R2 gene. We demonstrate multiple simultaneous c-Myc-induced R2 replication forks, whereas R2 normally replicates with a single fork. In contrast, cyclin C replicates with only a single replication fork irrespective of c-Myc deregulation. In addition to de novo replication forks, cMyc also initiates bi-allelic replication of R2, abrogating its normal mono-allelic replication pattern. Moreover, several chromosomal regions also display c-Myc-induced illegitimate replication pro®les. Thus, c-Myc can act as an illegitimate replication-licensing factor that promotes de novo replication initiation and illegitimate replication timing that adversely impacts upon genomic stability. Oncogene (2002) 21, 909 ± 920.
Introduction
Gene ampli®cation has been studied in in vitro models, mostly using DNA synthesis-inhibiting drugs (Wahl et al., 1979; Brown et al., 1983; Johnston et al., 1983; Knudson, 1986; Meinkoth et al., 1987; Schimke, 1988; Tlsty et al., 1989; Smith et al., 1990 Smith et al., , 1992 . Gene ampli®cation is thought to initiate through either replication-or segregation-driven mechanisms. The replication-driven model [also termed the`onion-skin ' model] postulates that rereplication of a gene occurs within a single cell cycle. This model allows for the formation of intrachromosomal ampli®cation. It can also account for the formation of extrachromosomal DNA molecules that are released from their chromosomal locations by recombination. A well-known example is the ampli®cation of chorion genes during Drosophila oogenesis (Spradling, 1981) . The segregation-driven models include the`deletion plus episome' and the`chromatid exchange' models (for review see Stark, 1993) . During the segregation-driven process, genes may be deleted from their chromosomal location (Morris and Thacker, 1993; Carroll et al., 1988) subsequently becoming extrachromosomal elements, episomes, or double minutes. Examples of this model are the ribosomal DNA (rDNA) amplicons in Tetrahymena. rDNA ampli®cation in this organism involves speci®c breaks next to inverted repeats (Butler et al., 1996) . In mammalian cells, the segregation-driven model includes breakage-bridge-fusion cycles that are instrumental in the generation of drug-induced amplicons Poupon et al., 1996) . In agreement with this model are data demonstrating that a double strand break is sucient to initiate gene ampli®cation (Pipiras et al., 1998) . Thus, initiating events in drug-induced gene ampli®cation involve chromosome breakage, deletion, inverted duplication, and terminal fusions (Wahl et al., 1979; Ruiz and Wahl, 1988; Hamlin and Ma, 1990; Smith et al., 1990 Smith et al., , 1992 Ma et al., 1993; Poupon et al., 1996; Pipiras et al., 1998; Singer et al., 2000) .
The initiating events in non-drug-dependent gene ampli®cation are not known. Previous work has established that c-Myc deregulation initiates locusspeci®c gene ampli®cation (Denis et al., 1991; Mai, 1994; Mai et al., 1996a Mai et al., , 1999 , which is reversible in vitro (Mai et al., 1996a) , and karyotypic instability (Mai et al., 1996a; Felsher and Bishop, 1999a) , which is reversible in vivo (Felsher and Bishop, 1999b) . c-Myc-dependent gene ampli®cation is associated with the binding of c-Myc/Max heterodimers to E-boxes located on c-Myc target genes (Mai and Jalava, 1994; Wells et al., 1996) . c-Myc/Max heterodimers in cell-free extracts from proliferating cells and in vivo were shown to bind two adjacent 5'-anking E-box motifs of the dihydrofolate reductase (DHFR) gene (Mai and Jalava, 1994; Wells et al., 1996) and to four E-boxes located in the 5'-¯anking region of cyclin D2 (CCND2) . In these studies, c-Myc/Max heterodimer binding was correlated with cellular proliferation and DNA synthesis. Regulatable c-Myc overexpression preceded enhanced binding of cMyc/Max heterodimers to the 5'-¯anking E-box motifs in both DHFR and CCND2 (Mai, 1994; Mai et al., 1996a Mai et al., , 1999 . Recently, the mouse ribonucleotide reductase R2 (R2) gene has been identi®ed as a cMyc ampli®cation target gene: Transient c-Myc overexpression leads to chromosomal and extrachromosomal ampli®cation, and rearrangements of the active R2 gene . Previous data have not addressed the initiation mechanism of c-Myc-dependent gene ampli®cation. Here, we demonstrate that overexpression of c-Myc initiates illegitimate DNA replication and overrides Figure 1 Bromodeoxyuridine incorporation into Pre-B7 and Pre-B+ cells. BrdU was pulsed into Pre-B cells during synchronization and at 0, 24, 48, and 72 h after mock or 4-HT activation. Cells incorporated no BrdU following a 48 h incubation in isoleucine-depleted (ILE-) medium (A) or after 12 h incubation in medium containing 400 mM L-mimosine (B). After mock or 4-HT activation, low BrdU was taken up in either Pre-B7 cells (C) or Pre-B+ cells (G). Signi®cant BrdU incorporation dierences were observed at 24 hours, where Pre-B+ (H) cells took up more BrdU than Pre-B7 cells (D) (P50.0001) and at 48 h where Pre-B+ (I) cells took up more BrdU than Pre-B7 cells (E) (P=0.0159). No signi®cant dierences in BrdU uptake between Pre-B7 and Pre-B+ cells were observed at 72 h (F, J) c-Myc-dependent illegitimate replication of R2 TI Kuschak et al replication timing of the R2 gene, which precedes the previously described c-Myc-induced ampli®cation and rearrangement of R2 . In an experimental mouse Pre-B cell system that harbors a 4-hydroxytamoxifen-(4-HT) regulatable Myc-ER TM construct (Little- Figure 2 Illegitimate R2 replication occurs within 24 hours of c-Myc deregulation. The 2D gel separates restricted DNA in the ®rst dimension by dierential mass, whereas in the second dimension, the DNA is separated based on mass and hydrodynamic volume. Hence, in the second dimension the shape (single, double, symmetric or asymmetric shape of forks as well as replication bubbles) will aect migration as will the mass of a strand of DNA as it undergoes replication (i.e. as the mass of DNA increases from n to 2n). (a) 2D gel electrophoresis and Southern analyses of non-activated (Pre-B7) (A ± D) and 4-HT-activated (Pre-B+) cells (E ± H) at 0, 24, 48 and 72 h after synchronizing and seeding into complete medium (Wang et al., 1998) . The membranes were probed with a 1487 bp PstI R2 cDNA fragment (Thelander and Berg, 1986) . Schematic illustrations depict the replication status of the R2 locus at each corresponding time point (A' ± H'). Replication forks in schematic are drawn in red. R2 pseudogenes (top left:A ± H) are not aected by c-Myc activation (see also and were not highlighted in the schematic illustrations. A single arrow indicates a replication fork emerging from the active R2 locus in Pre-B7 cells (B, B'), while four arrows point to simultaneous replication forks emerging from the active R2 gene locus in Pre-B+ cells (F, F') at 24 h. No replication forks are present at the 0 (A, E), 48 (C, G) or 72 h (D, H) time points. (b) Cyclin C replication is unaltered by c-Myc. 2D membranes of genomic DNA from synchronized Pre-B7 and Pre-B+ cells (Wang et al., 1998) were probed with 400 and 500 bp EcoRI cyclin C cDNA fragments (Li et al., 1996) Figure 3 c-Myc interaction with R2 E-boxes precedes initiation of de novo rereplication (a) The mouse ribonucleotide reductase R2 (R2) gene. This ®gure is a schematic representation of the mouse R2 gene (Thelander and Berg, 1986) . It indicates the E-boxcontaining oligonucleotides and shows their relative location within the¯anking region of exon VIII of the R2 gene. R2 ± 2 spans nucleotides 4761 ± 4785, R2 ± 3 spans nucleotides 4781 ± 4805, R2 ± 4 spans nucleotides 4816 ± 4840, and R2 ± 5 spans nucleotides 4916 ± 4940. The non-canonical E-box motifs are highlighted in bold. (b) c-Myc and Max interact with E-box motifs in the R2 gene.
(A) Proteins complex formation with R2 oligonucleotides. Whole cell extracts (Mai and Jalava, 1994 ) from NIH3T3 cells bind each of the four [32] P-5'-end-labeled R2 oligonucleotides (a) and the [32] P-5'-end-labeled DHFRI oligonucleotide (Mai and Jalava, 1994) . The R2 oligonucleotides were loaded in the absence (lanes 1, 3, 5 and 7) or presence of 5 mg of cell extract (lanes 2, 4, 6 and 8). DHFRI was loaded into lanes 9 and 10 in the absence (lane 9) and presence (lane 10) of extract. The arrow indicates the position of a DNA/protein complex common to the R2 and DHFRI oligonucleotides (B) Anti-c-Myc antibody disrupts R2 oligonucleotide/ protein complex formation. Protein binding to R2 E-box containing oligonucleotides (a) is disrupted in the presence of increasing concentrations of anti-c-Myc antibody, but unaected by control antibodies and shown in a representative EMSA experiment using the R2 ± 5 oligonucleotide. Similar data were obtained with each of the other R2 oligonucleotides (not shown). Lane 1: R2 ± 5 alone;
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Results
Our previous work described the locus-speci®c chromosomal and extrachromosomal ampli®cation, and rearrangement of the mouse ribonucleotide reductase R2 gene 72 h after transient c-Myc deregulation . Our current work focuses on the initiation mechanism of c-Myc-dependent R2 gene ampli®cation. In this study we used cultured mouse Pre-B cells that harbor a 4-hydroxytamoxifen-(4HT) responsive Myc-ER TM construct (Materials and methods).
Cell cycle arrest and synchronization and Myc-ER TM activation
To study the eects of c-Myc on the initiation of locus-speci®c DNA ampli®cation, we analysed the initiation of R2 gene ampli®cation in cell cycle synchronized Myc-ER TM -activated (Pre-B+) cells, while using cell cycle synchronized mock-activated (Pre-B7) cells as controls (Materials and methods). To demonstrate Myc-ER TM activation and cell cycle synchronization, we carried out quantitative¯uores-cent immunostaining, bromodeoxyuridine (BrdU) incorporation, and determined the mitotic indices (Materials and methods). Nuclear c-Myc levels were measured during each experiment to ensure successful Myc-ER TM activation. Nuclear c-Myc protein levels were found signi®cantly higher in 4-HT-treated, cMyc-activated Pre-B+ than in mock treated Pre-B7 cells 24 h after Myc-ER TM activation (P50.005). We also measured BrdU incorporation to determine whether Myc-ER TM -activated cells showed increased rates of DNA replication. Cell cycle synchronization was evident by the absence of BrdU incorporation during the synchronization process when cells were incubated in isoleucine-depleted (ILE-) medium (Figure 1a) or in medium containing 400 mM L-mimosine (Figure 1b) . BrdU incorporation was then measured at 0, 24, 48 and 72 h after mock or 4-HT treatment. Pre-B+ cells incorporated signi®cantly more BrdU than Pre-B7 cells at 24 h (P50.0001) ( Figure 1D ,H) and 48 h (P=0.0159) ( Figure 1E,I ) as indicated by Kruskal-Wallis tests, marking enhanced DNA replication rates in c-Myc-deregulated cells. Signi®cant changes were not evident at 72 h ( Figure 1F,I ). Moreover, we examined whether c-Myc deregulated cells exhibited enhanced cellular proliferation rates. At 24 h, we observed a twofold increase in the mitotic index of Pre-B+ cells (3.4% in Pre-B+ vs 1.7% in Pre-B7 cells). Together, these data indicate Myc-ER TM activation, increased BrdU incorporation and cellular proliferation within 24 h of Myc-ER TM activation.
c-Myc induces de novo replication of R2 in Pre-B cells Next, we examined whether c-Myc-dependent ampli®cation of the R2 gene occurred through a replication-mediated mechanism using a strictly controlled experimental system. Genomic DNA from cell cycle synchronized Pre-B7 and Pre-B+ cells (Wang et al., 1998) was analysed by neutral-neutral two-dimensional (2D) gel electrophoresis at 0, 24, 48 and 72 h. The DNA samples were digested with HindIII, leaving the active R2 gene uncut (Thelander and Berg, 1986) . We found a single replication fork in Pre-B7 cells at the active R2 gene 24 h after synchronization and seeding into complete medium (Figure 2a (B,B' ), arrow). In contrast, in cMyc-activated Pre-B+ cells we observed several replication forks originating simultaneously at 24 h from the active R2 gene (Figure 2a (F,F' ), arrows). We found an increase in R2 gene copy number in Pre-B+ cells 48 and 72 h after Myc-ER TM activation (Figure 2a (G,G',H,H') (see also . c-Myc upregulation did not alter the replication pro®le of all genes. This is evident from the unaltered replication pattern observed for a control gene, cyclin C (CCNC) (Li et al., 1996) (Figure 1b) , indicating that c-Myc-mediated illegitimate replication functions in a gene-and chromosomal region-speci®c context.
c-Myc/Max heterodimer interaction with R2 E-boxes
To understand the role of c-Myc in the initiation of illegitimate R2 replication, we investigated the direct interaction of c-Myc/Max heterodimers with E-boxes in the R2 gene. A cluster of four non-canonical (see Blackwell et al., 1993) E-boxes was identi®ed in the regions¯anking exon VIII of the mouse R2 gene (Figure 3a) . To examine c-Myc/Max binding at these four sites, we designed oligonucleotides and performed electromobility shift assays (EMSA), competition, supershift, and glutathione-S-transferase (GST)-fusion protein experiments. Established positive and negative binding sites were used as internal controls. The positive control oligonucleotide, DHFRI, was shown to bind c-Myc/Max heterodimers in EMSA and footprinting experiments (Mai and Jalava, 1994 , 1996) . The negative control oligonucleotide, DHFRm, is a point-mutated version of DHFRI that is unable to bind c-Myc/Max heterodimers (Mai and Jalava, 1994) . Cell extracts from proliferating cells showed complex formation with each of the R2 and DHFRI oligonucleotides (Figure 3b (A), arrow) . Competition experiments con®rmed these ®ndings and showed that each R2 E-box-containing oligonucleotide as well as DHFRI, but not with DHFRm, is able to bind the same protein complexes (data not shown). To conclusively prove c-Myc/Max binding to each of the R2 oligonucleotides, we carried out supershift experiments using an anti-c-Myc antibody (Mai and Jalava, 1994) . We observed that R2-5 oligonucleotide/protein complexes were supershifted in the presence of increasing amounts of anti-c-Myc antibody ( Figure  3b (Figure 3b , lane 17). Complex disruption was observed in experiments with R2 ± 2, R2 ± 3, and R2 ± 4, as was the inability to disrupt complexes with control antibodies (not shown). In addition, GST-Myc and GST-Max fusion proteins (Mai and MaÊ rtensson, 1995) formed complexes with each of the R2 oligonucleotides (not shown). Together, these data demonstrate the speci®c interaction of the c-Myc/Max proteins with the R2 E-box sequences.
R2 E-boxes are part of c-Myc-induced illegitimate R2 replication profiles in Pre-B cells
To determine whether the four R2 E-box-containing oligonucleotides were part of c-Myc-induced illegitimate R2 replication pro®les, we carried out neutral ± neutral 2D gel electrophoresis. Using genomic DNA from synchronized Pre-B7 and Pre-B+ cells, we examined the hybridization signals of each of the four R2 E-box-containing oligonucleotides (Figure 3c ). In Pre-B+ cells, at the 24 h time point each R2 oligonucleotides hybridized to two replication forks simultaneously (Figure 3c, arrows) . In contrast, in Pre-B7 cells, probing with the R2 E-box-containing oligonucleotides detected no replication forks at any of the 0, 24, 48 or 72 h time points (Figure 3c ). Together these data indicate that each of the R2 Eboxes is part of the c-Myc-dependent illegitimate de novo R2 replication pro®les in Pre-B+ cells.
c-Myc-induced de novo replication profiles on mouse chromosome 12
We surmized that de novo replication of R2 would be detectable at the chromosomal level, speci®cally on band A of mouse chromosome 12, where the mouse R2 gene is located (Khan et al., 1994) . Thus, we assessed directly whether the presence of c-Myc-dependent de novo replication forks was paralleled by an increase in BrdU incorporation into the R2 locus on mouse chromosome 12 (band A) during the initiation of R2 DNA replication. Using a pulse of BrdU incorporation into Pre-B7 and Pre-B+ cells in vivo, we examined a potential increase either in relative signal intensity of BrdU at chromosome 12 band A, and/or an increase in the length of the BrdU signal in Pre-B+ chromosomes 12 (Materials and methods). Pre-B7 cells showed a single peak of BrdU incorporation into one R2 allele at the 24 h time point (Figure 4a (B,E) ). In contrast, Pre-B+ chromosomes 12 showed increased BrdU signal intensity ratios in one or both bands A of chromosome 12 (P=0.0480) (Figure 4a (D,F) and b). Furthermore, the Pre-B+ metaphases displayed increased length of BrdU incorporation signals in one or both bands A of one or both chromosomes 12 (log 10 ratio P=0.0133) (Figure 4a (D,F) and b) . This suggests that under normal, non-c-Myc activating conditions, the R2 gene replicates its two alleles at dierent times, i.e., one allele replicates before the other. Asynchronous replication timing patterns for Igf2, Igf2r, H19 and Snrpn in the mouse was described by Kitsberg et al. (1993) . Later, Simon et al. (1999) showed that asynchronous replication of imprinted genes is established in the gametes and maintained during the course of development. In contrast, c-Myc-upregulated Pre-B+ cells can replicate their R2 loci simultaneously in a bi-allelic fashion, indicating that c-Myc overexpression can result in disruption of allelic replication timing (Figure 4c (C,E,F) ). In addition, it is worth noting that many other chromosomes in Pre-B+ metaphases displayed c-Myc-dependent alterations in their BrdU incorporation pro®les when compared to their Pre-B7 controls (Figure 4a (A ± D) ), suggesting that cMyc can initiate additional illegitimate replication pro®les. Thus, c-Myc upregulation results in the overreplication of R2 and in alterations in replication timing of the R2 alleles. Moreover, the inappropriate expression of c-Myc protein enhances replication beyond the chromosomal region that carries R2 and can also aect additional chromosomal sites.
Discussion
Earlier work had implicated c-Myc in the enhanced replication of Simian Virus 40 (SV 40) in human lymphoma cells: Elevated levels of c-Myc protein allowed for over-replication of the virus (Classon et al., 1987; Henriksson et al., 1988) . More recently, it was shown that c-Myc overexpression can lead to DNA endoreduplication and polyploidy (Li and Dang, 1999; Gandarillas et al., 2000) . Li and Dang (1999) examined the role of c-Myc in the replication process in human and rodent cells. They observed that c-Myc was able to promote endoreduplication in the presence of a mitotic block. Myc and endoreduplication were reported by Gandarillas et al. (2000) , who showed that the upregulation of c-Myc protein levels led to endoreduplication in keratinocytes prior to their terminal dierentiation.
Oncogene c-Myc-dependent illegitimate replication of R2 TI Kuschak et al Our current work also points to a function of c-Myc in replication. In contrast to previous data that described c-Myc-induced overall endoreduplication, we ®nd non-random illegitimate replication events that are initiated by c-Myc deregulation. Using a regulatable Myc-ER TM system (Littlewood et al., 1995) that was stably introduced into in a Pre-B lymphocyte line , we demonstrate that c-Myc initiates locus-and chromosomal region-speci®c illegitimate replication events that aect the timing and extent of DNA replication (Figure 1 ±  4) . The locus-speci®c example studied here is R2, where we observe de novo re-replication pro®les and altered timing following c-Myc deregulation. In contrast, cyclin C was unaltered under identical experimental conditions. We studied mouse chromosome 12 (band A), with enhanced DNA replication following c-Myc deregulation, as an example of c-Myc-dependent chromosomal region-speci®c changes in replication. In addition, we noted that many other chromosomes showed region-speci®c alterations in their replication pro®les.
Based on our present data describing c-Mycdependent illegitimate replication initiation, we propose that c-Myc protein overexpression illegitimately licenses the use of multiple replication initiation sites of R2 that are silent under normal, non-c-Mycderegulated conditions. Simultaneously, c-Myc enhances replication of a chromosomal region that expands beyond the R2 locus on mouse chromosome 12 and induces enhanced replication of additional regions on other chromosomes. Such illegitimate replication aects the stability of R2 and presumably other genes in this and additional chromosomal regions, setting the stage for both intrachromosomal and extrachromosomal ampli®cation that involves R2 (Kuschak et al., 1999) and other genes (Mai, 1994; Mai et al., 1996a Mai et al., , 1999 . Global changes in replication initiation and timing will contribute to the dynamics of karyotypic instability (Mai et al., 1996b; Felsher and Bishop, 1999a,b) via DNA breakage, deletions, chromosomal rearrangements, and fusions. It is evident that replication-driven mechanisms act early during cMyc-dependent initiation of R2 gene ampli®cation. However, it is also likely that resulting DNA breakage at the R2 locus and at other chromosomal sites, in addition to fusions, deletions and recombination events, will further add to the dynamics of genomic instability, setting the stage for early neoplasia. In conclusion, we propose that c-Myc can act as an illegitimate replication-promoting or replication licensing factor and initiate genomic instability of R2 through replication-driven mechanism.
Materials and methods

Cell culture
The studies were performed using cultured mouse Pre-B cells that harbor a 4-hydroxytamoxifen-(4HT) responsive Myc-ER TM construct (Littlewood et al., 1995) . The culture and activation of these cells is described .
EMSA
Electromobility shift assays (EMSA) were performed as described (Mai and Jalava, 1994) . Brie¯y, DNA/protein interactions of four oligonucleotide sequences from the R2 gene were tested (Figure 3a) . The sequences of the oligonucleotides tested were as follows: R2-2: 5'-AAGT-CATGCATGTGAACAGTAGAG-3'; R2-3: 5'-GAGCCC-CACGGTGACCTTGAACG-3'; R2-4: 5'-TAGGGTTTAC-ACTGTGACTTTGCC-3'; R2-5: 5'-ATAGAGCAGGTGA-GTGACTGCGTGC-3'. The E-box motifs are underlined. Positive and negative control oligonucleotides DHFRI and DHFRm, respectively, are described in (Mai and Jalava, 1994) . The antibodies used were as follows: pan-Myc Clone M-911-94 antibody (Genosys). Anti-c-Fos (Clone (4)-G), anti-USF-1 (Clone 20), and anti-Mxi-1 (Clone 17) were from Santa Cruz Biotechnology, Inc (Santa Cruz, USA). EMSA assays were also conducted using GST-Myc and GST-Max fusion proteins, as described (Mai and MaÊ rtensson, 1995) .
Neutral ± neutral 2 dimensional gel electrophoresis
Neutral ± neutral 2-dimensional (2D) gel electrophoresis was performed as follows: Genomic DNA was isolated from synchronized (Wang et al., 1998) , non-activated and 4-HTactivated cells by standard procedures. One hundred mg of each DNA sample was digested overnight at 378C with HindIII (Roche Diagnostics, Laval, QueÂ bec, Canada) and roto-evaporated to a 40 mL volume. The samples were electrophoresed in two dimensions under neutral ± neutral conditions . The 2D gels were washed and blotted . The following probes were used: A 1487 base pairs (bp) PstI R2 cDNA (Thelander and Berg, 1986) fragment, R2 oligonucleotide 20-mers corresponding to regions of the R2 gene containing E-box motifs, and two EcoRI cyclin C (CCNC) fragments (400 and 500 bp) (Li et al., 1996) . These were labeled by random priming . Southern blots probed with the R2 and CCNC cDNAs were hybridized as described . Oligonucleotide-probed membranes were hybridized as described (Mai et al., 1996a) and washed at 428C.
Bromodeoxyuridine incorporation assays
All bromodeoxyuridine (BrdU) incorporation assays were conducted in synchronized (Wang et al., 1998) Pre-B7 and Pre-B+ cells . BrdU incorporation and DNA replication was assessed during synchronization and at 0, 24, 48 and 72 h after seeding into complete medium and following mock-treatment (95% ethanol) or c-Myc activation (4-HT treatment). Cells were incubated in 10 mM BrdU (Sigma-Aldrich Chemical Company, Winston, ON, Canada) for 15 min. BrdU incorporation into replicating DNA was assayed by quantitativē uorescent immunostaining using a mouse monoclonal antiBrdU antibody (Becton Dickinson, San Jose, USA). Over 100 cells were counted in each experiment. Relative BrdU intensity levels for each set of cells were tested for signi®cance using a Kruskal-Wallis non-parametric test. Chromosome 12-speci®c BrdU uptake was measured in metaphase spreads of synchronized Pre-B7 and Pre-B+ cells following a 30 min 10 mM BrdU pulse at 24 h. Chromosomes were prepared as described (Mai, 1994) following a 24 h incubation in fresh medium. BrdU was visualized as described (Leonhardt et al., 1992) , with modi®cations. Metaphase chromosomes from BrdU-incubated cells were banded as described (Wiener and Mai, 2000) , visualized (Zeiss Axiophot microscope, Carl Zeiss Canada Ltd.), and images were acquired (Photometrics CH250/a CCD camera). The chromosomes were subsequently stained for BrdU incorporation and visualized usinḡ uorescein isothiocyanate-(FITC) conjugated anti-BrdU (Becton Dickinson), followed by signal ampli®cation with rabbit anti-FITC (Cambio, Cambridge, UK) (25 ng mL 71 ) and FITC-conjugated goat anti-rabbit IgG (H and L) (Pierce, Rockford, USA) (25 ng mL 1 ). DAPI and BrdU signal intensities and lengths along chromosomes 12 were measured (IPLab software, Scanalytics, Fairfax, VA, USA). Statistical signi®cance of BrdU signal intensity and signal length dierences between Pre-B7 and Pre-B+ chromosomes 12 were compared using a Kruskal-Wallis nonparametric test. The Kruskal-Wallis non-parametric analysis Pre-B+ chromosomes 12 (band A) are signi®cant (P=0.0725). Also, the log 10 of the dierence ratios of the lengths between the Pre-B7 and Pre-B+ chromosome 12 chromatids are signi®cant (P=0.0133). 
Mitotic indices
Mitotic indices of synchronized (Wang et al., 1998) Pre-B7 and Pre-B+ cells were assessed 24 h after mock or 4-HT activation. Cells were cytospun onto microscope slides, stained with 4'6' diamidino-2-phenylindole (DAPI) (1 mg mL 1 ), analysed on a Carl Zeiss Axioplan 2 (Carl Zeiss Canada, Ltd.) microscope (at 406magni®cation), and images were captured on a Sony XC75 CCD camera. Mitotic cells were counted from among a total of 800 cells in each group.
